Clinical Trials Directory

Trials / Completed

CompletedNCT02990013

AvenovaTM as a Sterile Skin Preparation Agent

Comparison of Antimicrobial Activity of AvenovaTM as a Sterile Skin Preparation in Humans

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aim 1: To determine in vivo capability of AvenovaTM against common cutaneous microbial biome on human skin Aim 2: To compare to povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol against AvenovaTM as a sterile skin agent

Detailed description

A total of approximately 30 eligible participants will be identified with clinically-acquired information by Dr. Wendy Lee, an oculoplastic surgeon and aesthetic treatment specialist at Bascom Palmer Eye Institute, during regular clinic visits. Part One: Patients will have their skin swabbed and then cultured for various skin flora agents. The petri dish will then be swabbed with Avenova to see what percent of skin flora microbe is killed. Part Two: Patients will have their skin divided into 4 quadrants. The area will be pre-swabbed to monitor microbe growth. Each of 4 quadrants will be cleansed for one minute with AvenovaTM , povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol, then swabbed to monitor for microbe growth. The swabs will be placed in thioglycollate broth to monitor for bacterial growth. If growth if observed in the thioglycollate, the samples will be cultured on blood agar plates and the bacterial specie(s) identified.

Conditions

Interventions

TypeNameDescription
DEVICEAvenovaSubjects will all undergo the treatment arm where their skin will be cleansed with four different agents: AvenovaTM , povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol
DRUGPovidone-iodine 5% solutionSubjects will all undergo the treatment arm where their skin will be cleansed with four different agents: AvenovaTM , povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol
DRUG4% chlorhexidineSubjects will all undergo the treatment arm where their skin will be cleansed with four different agents: AvenovaTM , povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol
DRUGIsopropyl alcoholSubjects will all undergo the treatment arm where their skin will be cleansed with four different agents: AvenovaTM , povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol

Timeline

Start date
2018-12-01
Primary completion
2019-12-20
Completion
2019-12-20
First posted
2016-12-12
Last updated
2020-02-05

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02990013. Inclusion in this directory is not an endorsement.